Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review

Abstract Introduction Biological drugs (BD) and Janus kinase inhibitors (JAKi) have revolutionized the treatment of diverse dermatoses. However, there are concerns regarding their safety, especially the risk of cancer and opportunistic infections. Here, we discuss the risk of cancer associated with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miguel Mansilla-Polo (Autor), Daniel Morgado-Carrasco (Autor)
Formato: Libro
Publicado: Adis, Springer Healthcare, 2024-05-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible